TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation

Journal of Immunology

Volumn 185, Issue 1, 2010, Pages 748-755

  Kuijf, Mark L ^a   Samsom, Janneke N ^a   Van Rijs, Wouter ^a   Bax, Marieke ^b   Huizinga, Ruth ^a   Heikema, Astrid P ^a   Van Doorn, Pieter A ^a   Van Belkum, Alex ^a   Van Kooyk, Yvette ^b   Burgers, Peter C ^a   Luider, Theo M ^a   Endtz, Hubert P ^a,c   Nieuwenhuis, Edward E S ^a   Jacobs, Bart C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; INTERLEUKIN 8; LIPOOLIGOSACCHARIDE; NEUTRALIZING ANTIBODY; SIALIC ACID; SIALIDASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ALPHA N ACETYLNEURAMINATE ALPHA 2,8 SIALYLTRANSFERASE; ALPHA-N-ACETYLNEURAMINATE ALPHA-2,8-SIALYLTRANSFERASE; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CYTOKINE; LIPID LINKED OLIGOSACCHARIDES; LIPID-LINKED OLIGOSACCHARIDES; LIPOPOLYSACCHARIDE; SIALIC ACID DERIVATIVE; SIALYLTRANSFERASE; TLR4 PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAMPYLOBACTER JEJUNI; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CROSS LINKING; CROSS REACTION; CYTOKINE RELEASE; DENDRITIC CELL; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOLECULAR MIMICRY; MUTANT; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; SIALYLATION; SIALYLTRANSFERASE GENE; SIGNAL TRANSDUCTION; SUPERNATANT; T LYMPHOCYTE; WILD TYPE; ANIMAL; BIOSYNTHESIS; C3H MOUSE; CARBOHYDRATE ANALYSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL FREE SYSTEM; CELL LINE; CELL PROLIFERATION; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; GENE TARGETING; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE; PHYSIOLOGY; SECRETION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; B-LYMPHOCYTE SUBSETS; CAMPYLOBACTER JEJUNI; CARBOHYDRATE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL-FREE SYSTEM; CELLS, CULTURED; CROSS REACTIONS; CYTOKINES; DENDRITIC CELLS; GENE KNOCK-IN TECHNIQUES; GUILLAIN-BARRE SYNDROME; HUMANS; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; SIALIC ACIDS; SIALYLTRANSFERASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 77956207001     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903014     Document Type: Article

References (39)

1. Jacobs, B. C., P. H. Rothbarth, F. G. van der Meché, P. Herbrink, P. I. Schmitz, M. A. de Klerk, and P. A. van Doorn. 1998. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 51: 1110-1115.
2. van Koningsveld, R., E. W. Steyerberg, R. A. Hughes, A. V. Swan, P. A. van Doorn, and B. C. Jacobs. 2007. A clinical prognostic scoring system for Guillain- Barré syndrome. Lancet Neurol. 6: 589-594.
3. Yuki, N., and S. Kuwabara. 2007. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology. J. Peripher. Nerv. Syst. 12: 238-249.
4. Willison, H. J. 2005. The immunobiology of Guillain-Barré syndromes. J. Peripher. Nerv. Syst. 10: 94-112.
5. Ang, C. W., J. D. Laman, H. J. Willison, E. R. Wagner, H. P. Endtz, M. A. De Klerk, A. P. Tio-Gillen, N. Van den Braak, B. C. Jacobs, and P. A. Van Doorn. 2002. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infect. Immun. 70: 1202-1208.
6. Godschalk, P. C., M. L. Kuijf, J. Li, F. St Michael, C. W. Ang, B. C. Jacobs, M. F. Karwaski, D. Brochu, A. Moterassed, H. P. Endtz, et al. 2007. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect. Immun. 75: 1245-1254.
7. Jacobs, B. C., M. P. Hazenberg, P. A. van Doorn, H. P. Endtz, and F. G. van der Meché. 1997. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J. Infect. Dis. 175: 729-733.
8. Yuki, N., K. Susuki, M. Koga, Y. Nishimoto, M. Odaka, K. Hirata, K. Taguchi, T. Miyatake, K. Furukawa, T. Kobata, and M. Yamada. 2004. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc. Natl. Acad. Sci. USA 101: 11404-11409.
9. Godschalk, P. C., A. P. Heikema, M. Gilbert, T. Komagamine, C. W. Ang, J. Glerum, D. Brochu, J. Li, N. Yuki, B. C. Jacobs, et al. 2004. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain- Barre syndrome. J. Clin. Invest. 114: 1659-1665.
10. van Belkum, A., N. van den Braak, P. Godschalk, W. Ang, B. Jacobs, M. Gilbert, W. Wakarchuk, H. Verbrugh, and H. Endtz. 2001. A Campylobacter jejuni gene associated with immune-mediated neuropathy. Nat. Med. 7: 752-753.
11. Bouchet, V., D. W. Hood, J. Li, J. R. Brisson, G. A. Randle, A. Martin, Z. Li, R. Goldstein, E. K. Schweda, S. I. Pelton, et al. 2003. Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc. Natl. Acad. Sci. USA 100: 8898-8903.
12. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
13. van Koningsveld, R., P. I. Schmitz, F. G. Meché, L. H. Visser, J. Meulstee, and P. A. van Doorn; Dutch GBS study group. 2004. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain- Barré syndrome: randomised trial. Lancet 363: 192-196.
14. Asbury, A. K., and D. R. Cornblath. 1990. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27(Suppl.): S21-24.
15. Ang, C. W., K. Krogfelt, P. Herbrink, J. Keijser, W. van Pelt, T. Dalby, M. Kuijf, B. C. Jacobs, M. P. Bergman, P. Schiellerup, and C. E. Visser. 2007. Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients. Clin. Microbiol. Infect. 13: 915-922.
16. Louwen, R., A. Heikema, A. van Belkum, A. Ott, M. Gilbert, W. Ang, H. P. Endtz, M. P. Bergman, and E. E. Nieuwenhuis. 2008. The sialylated lipo-oligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion. Infect. Immun. 76: 4431-4438.
17. Hanniffy, O. M., A. S. Shashkov, A. P. Moran, M. M. Prendergast, S. N. Senchenkova, Y. A. Knirel, and A. V. Savage. 1999. Chemical structure of a polysaccharide from Campylobacter jejuni 176.83 (serotype O:41) containing only furanose sugars. Carbohydr. Res. 319: 124-132.
18. Jacobs, B. C., H. P. Endtz, F. G. van der Meché, M. P. Hazenberg, M. A. de Klerk, and P. A. van Doorn. 1997. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome. J. Neuroimmunol. 79: 62-68. (Pubitemid 27454684)
19. Beutler, B., and E. T. Rietschel. 2003. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3: 169-176.
20. Latz, E., A. Visintin, E. Lien, K. A. Fitzgerald, B. G. Monks, E. A. Kurt-Jones, D. T. Golenbock, and T. Espevik. 2002. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277: 47834-47843.
21. Ruprecht, C. R., and A. Lanzavecchia. 2006. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur. J. Immunol. 36: 810-816.
22. Bourke, E., D. Bosisio, J. Golay, N. Polentarutti, and A. Mantovani. 2003. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 102: 956-963.
23. Dubois, B., B. Vanbervliet, J. Fayette, C. Massacrier, C. Van Kooten, F. Brière, J. Banchereau, and C. Caux. 1997. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185: 941-951.
24. Allos, B. M., and M. J. Blaser. 1995. Campylobacter jejuni and the expanding spectrum of related infections. Clin. Infect. Dis. 20: 1092-1099, quiz 1100-1101.
25. Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J. P. Kraehenbuhl, and P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2: 361-367.
26. Hu, L., M. D. Bray, M. Osorio, and D. J. Kopecko. 2006. Campylobacter jejuni induces maturation and cytokine production in human dendritic cells. Infect. Immun. 74: 2697-2705.
27. Maimone, D., P. Annunziata, I. L. Simone, P. Livrea, and G. C. Guazzi. 1993. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain- Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J. Neuroimmunol. 47: 55-61.
28. Sharief, M. K., D. A. Ingram, M. Swash, and E. J. Thompson. 1999. I.v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome. Neurology 52: 1833-1838.
29. Unkmeir, A., U. Kämmerer, A. Stade, C. Hübner, S. Haller, A. Kolb-Mäurer, M. Frosch, and G. Dietrich. 2002. Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells. Infect. Immun. 70: 2454-2462.
30. Ngampasutadol, J., S. Ram, S. Gulati, S. Agarwal, C. Li, A. Visintin, B. Monks, G. Madico, and P. A. Rice. 2008. Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J. Immunol. 180: 3426-3435.
31. Jones, C., M. Virji, and P. R. Crocker. 2003. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol. Microbiol. 49: 1213-1225.
32. Bowes, T., E. R. Wagner, J. Boffey, D. Nicholl, L. Cochrane, M. Benboubetra, J. Conner, K. Furukawa, K. Furukawa, and H. J.Willison. 2002. Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infect. Immun. 70: 5008-5018.
33. Jou, I., J. H. Lee, S. Y. Park, H. J. Yoon, E. H. Joe, and E. J. Park. 2006. Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am. J. Pathol. 168: 1619-1630.
34. Avril, T., E. R. Wagner, H. J. Willison, and P. R. Crocker. 2006. Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect. Immun. 74: 4133-4141.
35. Craxton, A., D. Magaletti, E. J. Ryan, and E. A. Clark. 2003. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101: 4464-4471.
36. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
37. Litinskiy, M. B., B. Nardelli, D. M. Hilbert, B. He, A. Schaffer, P. Casali, and A. Cerutti. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3: 822-829.
38. Matsumoto, Y., T. Kobata, M. Odaka, K. Furukawa, K. Hirata, and N. Yuki. 2010. BAFF aids generation of IgG anti-ganglioside antibodies in response to Campylobacter jejuni lipo-oligosaccharide. J. Neuroimmunol. 218: 67-72.
39. Johansen, F. E., E. S. Baekkevold, H. S. Carlsen, I. N. Farstad, D. Soler, and P. Brandtzaeg. 2005. Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils. Blood 106: 593-600.